As researchers gain a better understanding of cancer and how immunotherapies can help improve outcomes compared to traditional cancer treatments, there is a growing need for scientific tools that support the development of these novel therapies.
Chad Powell, Senior Molecular Business Manager, partners with clinical labs, hospitals, and other healthcare providers, ensuring they know how much we value them. The Atlanta-area resident joined Luminex in 2018, holds a bachelor’s degree in marketing from DePaul University, and is currently working toward an MBA from Kennesaw State University.
Scientists at Wageningen Prime Diagnostics often design multiplex assays to allow customers to test for many pathogens at once. They use Luminex’s bead-based multiplexing xMAP® Technology for streamlined development, reliable components, and robust test kits. Prime Diagnostics has been a Luminex Licensed Technologies Partner since 2007 and now offers more than 100 xMAP-based kits for pathogen detection in plants.
Multiplex immunoassays compared with brain cancer biomarker detection Accurately staging any cancer can be cha…
Now, scientists at the Mayo Clinic have a solution: they validated the Luminex xMAP® SARS-CoV-2 Multi-Antigen IgG Assay for use with dried blood spots, which can be collected with a finger stick.
Flow cytometry is an important, powerful tool for sorting, counting, and providing information about cells. But did you know that flow cytometers with the right sensitivity can also be useful for small particle analysis?
Throughout our product development cycles, we work closely with our customers to understand their needs and construct a solid understanding of our market. Josh Griffith, Senior Director of Marketing, Americas MDx, is one of our talented team members leading the way in crafting exceptional customer experiences. He joined Luminex in 2013 and holds a bachelor’s degree in biology from Drew University.
To help emerging scientists bridge the gap from college to careers in the life sciences, we offer an internship program in our LuminexPLORE custom assay development lab, where we introduce our interns to xMAP Technology.
In the newest generation of our xMAP® Technology, the xMAP® INTELLIFLEX DR-SE System, we’ve added more than a few exciting features, including the unique dual reporter functionality powered by a second reporter laser.
To better understand and monitor leukemia, researchers need tools that have both high throughput and high resolution. This combination is hard to find in conventional fluorescence in situ hybridization (FISH) platforms, which are often used to detect the presence of oncogenes and abnormal chromosome numbers.